Search This Blog

Friday, March 4, 2016

Lilly to Present Phase 3 Data at the American Academy of Dermatology (AAD) Annual Meeting for Ixekizumab in Psoriasis and Psoriatic Arthritis (NYSE:LLY)

Lilly to Present Phase 3 Data at the American Academy of Dermatology (AAD) Annual Meeting for Ixekizumab in Psoriasis and Psoriatic Arthritis (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.